Knowledge concerning the interaction of SARS-CoV-2 with human cells is sparse. We will use RNA-sequencing analysis, loss-of-function approaches and mechanistic studies to identify and characterize coding and non-coding genes that restrict viral replication. Taking advantage of some of these naturally occurring viral inhibitors may be an effective strategy in the development of novel drugs to treat the disease.
Related team publications: